Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks Holdings, Inc. is engaged in building the horizontal platform for cell programming. The Company's platform is used to program cells on behalf of its customers. Its cell programs are designed to enable biological production of products such as therapeutics, key food ingredients, and chemicals derived from petroleum. The Company operates through two segments: Foundry and Biosecurity. Foundry consists of research and development services performed under collaboration and license agreements relating to the Company’s cell programming platform. Its cell programming platform includes two assets: the Foundry, biology lab facilities, enabled by investment in workflows, custom software, robotic automation, and data science and analytics, which is paired with the Company’s Codebase, a collection of biological parts and a database of biological data used to program cells. Biosecurity consists of COVID-19 testing products and services primarily provided to public health authorities.
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake Wall St
- Deposit directly into your Stake wallet and you're ready to invest in DNA
This content does not constitute financial advice and has not been prepared to take into account your individual circumstances. As investments carry risk, you should do your own research and consider getting advice from a licensed tax or financial advisor before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.